Iglesias-Ussel Maria D, Zavadil Jiri, Scharff Matthew D
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
J Immunol Methods. 2009 Oct 31;350(1-2):71-8. doi: 10.1016/j.jim.2009.07.003. Epub 2009 Jul 17.
The hybridoma technology allows the production of large quantities of specific antibodies of a single isotype. Since different isotypes have special effector functions and are distributed distinctively throughout the body, it is often useful to have a library of switch variants from the original monoclonal antibody. We have shown previously that forced expression of activation induced cytidine deaminase (AID) in hybridomas increased their very low frequency of class switch recombination (CSR) in vitro only approximately 7-13 fold. Since we had previously identified rare hybridoma subclones that spontaneously switched at more than 100 times higher frequencies, we have now examined those higher switching variants to search for ways to further increase the frequency of isotype switching in vitro. AID was not responsible for the approximately 100 fold increase in CSR, so we used whole-genome gene expression profiling to provide a platform for studying candidate molecular pathways underlying spontaneous CSR in hybridomas.
杂交瘤技术能够产生大量单一同种型的特异性抗体。由于不同的同种型具有特殊的效应功能,且在全身分布各异,因此拥有一个源自原始单克隆抗体的类别转换变体文库通常很有用。我们之前已经表明,在杂交瘤中强制表达激活诱导胞嘧啶脱氨酶(AID)仅使它们在体外极低频率的类别转换重组(CSR)增加了约7至13倍。由于我们之前已经鉴定出罕见的杂交瘤亚克隆,其自发转换频率比这高出100倍以上,所以我们现在研究了那些更高转换频率的变体,以寻找进一步提高体外同种型转换频率的方法。AID并非导致CSR增加约100倍的原因,因此我们使用全基因组基因表达谱分析来提供一个平台,用于研究杂交瘤中自发CSR潜在的候选分子途径。